Stay updated on Daratumumab Combo in Relapsed Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo in Relapsed Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo in Relapsed Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.7%
    Check dated 2025-06-19T17:21:24.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T07:39:55.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T04:53:30.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:49:57.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new clinical trial involving Ixazomib for Recurrent Plasma Cell Myeloma, with significant details about the study's objectives and collaborators. The previous trial involving daratumumab has been removed, indicating a shift in focus.
    Difference
    55%
    Check dated 2025-04-16T01:44:49.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 6, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.2%
    Check dated 2025-04-08T20:25:05.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo in Relapsed Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in Relapsed Multiple Myeloma Clinical Trial page.